SynthesisPloS one2013

Combination of EGFR-TKIs and chemotherapy as first-line therapy for advanced NSCLC: a meta-analysis.

Pu-Yun OuYang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.